|
|
|
Volumn 103, Issue 2 Suppl 2, 2003, Pages
|
|
The Women's Health Initiative estrogen plus progestin trial: the study and how it changes our practice.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CONJUGATED ESTROGEN;
MEDROXYPROGESTERONE ACETATE;
PROGESTERONE DERIVATIVE;
AGED;
ARTICLE;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
ESTROGEN THERAPY;
FEMALE;
HUMAN;
MIDDLE AGED;
POSTMENOPAUSE;
RANDOMIZED CONTROLLED TRIAL;
RISK;
AGED;
CARDIOVASCULAR DISEASES;
ESTROGEN REPLACEMENT THERAPY;
ESTROGENS, CONJUGATED (USP);
FEMALE;
HUMANS;
MEDROXYPROGESTERONE 17-ACETATE;
MIDDLE AGED;
POSTMENOPAUSE;
PROGESTERONE CONGENERS;
RANDOMIZED CONTROLLED TRIALS;
RISK;
|
|
EID: 18344415807
PISSN: 00986151
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
